On Tuesday, June 6, at 1:00 p.m. ET, join the FDA’s Division of Drug Information for a webinar on the FDA’s role in medication error prevention. Specifically, the webinar will cover:
- The Division of Medication Error Prevention and Analysis’ role in pre-marketing and post-marketing activities to prevent and address medication errors
- Strategies aimed at increasing the safe use of drug products by minimizing use error that is related to the design, naming, labeling, and/or packaging of drug products
- Regulatory action taken to address recent medication errors
- How to identify, prevent, and mitigate medication errors
This session will be presented by Mishale Mistry, PharmD, MPH, acting associate director of the FDA’s division of medication error prevention and analysis. To register, please visit the FDA website.